Abstract: Provided are a method and apparatus for displaying an online document, and a storage medium. The method for displaying an online document includes, in response to receiving an interactive instruction for a first user through the online document, generating an online document notification message in the instant messaging session list of the first user, where the interactive instruction includes that a second user mentions the first user or that the second user mentions the content published by the first user in the online document; in response to receiving an instruction triggering the online document notification message, acquiring a target link address; and jumping to the target link address in an instant messaging window of the instant messaging client through a document container integrated into the instant messaging client and displaying the online document in the instant messaging window, where the document container is integrated into an instant messaging framework.

Abstract: Provided are a method and apparatus for displaying an online document, and a storage medium. The method for displaying an online document includes, in response to receiving an interactive instruction for a first user through the online document, generating an online document notification message in the instant messaging session list of the first user, where the interactive instruction includes that a second user mentions the first user or that the second user mentions the content published by the first user in the online document; in response to receiving an instruction triggering the online document notification message, acquiring a target link address; and jumping to the target link address in an instant messaging window of the instant messaging client through a document container integrated into the instant messaging client and displaying the online document in the instant messaging window, where the document container is integrated into an instant messaging framework.

Abstract: The present invention relates to the field of medicine, and specifically relates to a triazine compounds as represented by formula (I), or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound, and use of the compound and the pharmaceutical composition thereof in the preparation of drugs for treating and/or preventing proliferative disease, autoimmune diseases, allergic diseases, inflammatory diseases, transplant rejection, cancers, viral infectious diseases, or other diseases in mammals. The compound provided by the present invention exhibits excellent inhibitory activity and kinase selectivity against a target kinase.

Abstract: Provided are a method and apparatus for displaying an online document, an electronic device, and a storage medium. The method for displaying an online document includes, in response to receiving an interactive instruction for a first user through the online document, generating an online document notification message in the instant messaging session list of the first user, where the interactive instruction includes that a second user mentions the first user or that the second user mentions the content published by the first user in the online document; in response to receiving an instruction triggering the online document notification message, acquiring a target link address; and jumping to the target link address in an instant messaging window through a document container and displaying the online document in the instant messaging window, where the document container is integrated into an instant messaging framework.

Abstract: A method for performing view displaying on a table, a device for performing view displaying on a table, and an electronic device are provided. The method includes: receiving an editing instruction of a user on a target image bar in a target view, where the target view is generated based on target data in a preset data table; and editing the target image bar based on the editing instruction.

Abstract: Provided are a method and apparatus for displaying an online document, an electronic device, and a storage medium. The method for displaying an online document includes, in response to receiving an interactive instruction for a first user through the online document, generating an online document notification message in the instant messaging session list of the first user, where the interactive instruction includes that a second user mentions the first user or that the second user mentions the content published by the first user in the online document; in response to receiving an instruction triggering the online document notification message, acquiring a target link address; and jumping to the target link address in an instant messaging window through a document container and displaying the online document in the instant messaging window, where the document container is integrated into an instant messaging framework.

Abstract: The instant invention provides compounds of formulas Ia and Ib which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.

Abstract: The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.

Abstract: The instant invention provides compounds of formulas Ia and Ib which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.

Abstract: The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.

Abstract: The instant invention provides compounds of formula (I) which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.

Abstract: The present invention is directed to substituted triazolo bicyclic compounds of formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: The present invention is directed to pyrimidine carboxamide compounds of formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: The present invention is directed to dihydropyrazolopyrimidinone compounds of formulas (I) and (II) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: The instant invention provides compounds of formula (I) which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.

Abstract: The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.

Abstract: The present invention is directed to dihydropyrazolopyrimidinone compounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: The present invention is directed to 6-alkyl dihydropyrazolopyrimidinone compounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypo-function or basal ganglia dysfunction.

Abstract: The present invention is directed to pyrimidine carboxamide compounds of formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: The present invention is directed to substituted triazolo bicyclic compounds of formula I which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.